KRAS and cancer: KRAS functions as a GTPase and plays an important role in regulating cell differentiation, proliferation, and survival,42 where mutations in KRAS can be detected in approximately 30% of all human cancers.43 Point mutations at these active site residues can lead to the accumulation of cellular GTP-bound RAS, which activates downstream signaling pathways.